Here are six key headlines from spine and orthopedic robotics companies in the first quarter of 2023:
1. Paris-based Ganymed Robotics raised an additional 15 million Euros, or approximately $15.9 million, in Series B funding.
2. The global market for spine robots is expected to grow to $139.9 million, according to market research from Data Bridge.
3. In its fourth quarter earnings call, Stryker laid out its timeline for new Mako robot applications. The company's vice president of investor relations, Jason Beach, said there is "good progress" on Mako spine and shoulder's development, as transcribed by Seeking Alpha. Mako spine is expected to launch in the second half of 2024, and the initial shoulder launch is slated toward the end of 2024.
4. Zimmer Biomet's COO, Ivan Tornos, said the company's shoulder robot could launch before 2024. During Zimmer Biomet's earnings call, Mr. Tornos was asked about the company's robotic shoulder opportunity in light of Stryker's timeline. While he didn't provide a specific timeline, Mr. Tornos said a launch could be soon.
5. Stryker unveiled Mako 2.0, the next generation of its total knee replacement robot. Development for Mako 2.0 was informed by more than 500,000 total knee procedures with the robot's first iteration. Mako 2.0 has a new design and customizable workflow. It has three key components: 3D-CT -based planning, AccuStop haptic technology and data analytics.
6. Accelus' Remi spine robot recieved FDA 510(k) clearance for use with GE OEC 9900 C-Arm fluoroscopic imaging systems.